Kockx MM - Search Results

1

Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses.

Bais C, Mueller B, Brady MF, Mannel RS, Burger RA, Wei W, Marien KM, Kockx MM, Husain A, Birrer MJ; NRG Oncology/Gynecologic Oncology Group. Bais C, et al. Among authors: kockx mm. J Natl Cancer Inst. 2017 Nov 1;109(11):djx066. doi: 10.1093/jnci/djx066. J Natl Cancer Inst. 2017. PMID: 29059426 Free PMC article. Clinical Trial.

2

Predictive tissue biomarkers for bevacizumab-containing therapy in metastatic colorectal cancer: an update.

Marien KM, Croons V, Martinet W, De Loof H, Ung C, Waelput W, Scherer SJ, Kockx MM, De Meyer GR. Marien KM, et al. Among authors: kockx mm. Expert Rev Mol Diagn. 2015 Mar;15(3):399-414. doi: 10.1586/14737159.2015.993972. Epub 2015 Jan 13. Expert Rev Mol Diagn. 2015. PMID: 25585649 Review.

3

AutoTag and AutoSnap: Standardized, semi-automatic capture of regions of interest from whole slide images.

Marien KM, Andries L, De Schepper S, Kockx MM, De Meyer GR. Marien KM, et al. Among authors: kockx mm. MethodsX. 2015 May 21;2:272-7. doi: 10.1016/j.mex.2015.05.002. eCollection 2015. MethodsX. 2015. PMID: 26150998 Free PMC article.

4

Development and Validation of a Histological Method to Measure Microvessel Density in Whole-Slide Images of Cancer Tissue.

Marien KM, Croons V, Waumans Y, Sluydts E, De Schepper S, Andries L, Waelput W, Fransen E, Vermeulen PB, Kockx MM, De Meyer GR. Marien KM, et al. Among authors: kockx mm. PLoS One. 2016 Sep 1;11(9):e0161496. doi: 10.1371/journal.pone.0161496. eCollection 2016. PLoS One. 2016. PMID: 27583442 Free PMC article.

5

Tumor Fusion Burden as a Hallmark of Immune Infiltration in Prostate Cancer.

Wagle MC, Castillo J, Srinivasan S, Holcomb T, Yuen KC, Kadel EE, Mariathasan S, Halligan DL, Carr AR, Bylesjo M, McAdam PR, Lynagh S, Marien KM, Kockx M, Waumans Y, Huang SA, Lackner MR, Mounir Z. Wagle MC, et al. Cancer Immunol Res. 2020 Jul;8(7):844-850. doi: 10.1158/2326-6066.CIR-19-0568. Epub 2020 Apr 22. Cancer Immunol Res. 2020. PMID: 32321776

6

PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel-Treated Advanced Triple-Negative Breast Cancer.

Rugo HS, Loi S, Adams S, Schmid P, Schneeweiss A, Barrios CH, Iwata H, Diéras V, Winer EP, Kockx MM, Peeters D, Chui SY, Lin JC, Nguyen-Duc A, Viale G, Molinero L, Emens LA. Rugo HS, et al. Among authors: kockx mm. J Natl Cancer Inst. 2021 Nov 29;113(12):1733-1743. doi: 10.1093/jnci/djab108. J Natl Cancer Inst. 2021. PMID: 34097070 Free PMC article. Clinical Trial.

7

Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer.

Muilwijk T, Akand M, Daelemans S, Marien K, Waumans Y, Kockx M, Baekelandt L, Van den Broeck T, Van der Aa F, Gevaert T, Joniau S. Muilwijk T, et al. PLoS One. 2021 Sep 15;16(9):e0257195. doi: 10.1371/journal.pone.0257195. eCollection 2021. PLoS One. 2021. PMID: 34525114 Free PMC article.

8

Gene Expression Profiling in BRAF-Mutated Melanoma Reveals Patient Subgroups with Poor Outcomes to Vemurafenib That May Be Overcome by Cobimetinib Plus Vemurafenib.

Wongchenko MJ, McArthur GA, Dréno B, Larkin J, Ascierto PA, Sosman J, Andries L, Kockx M, Hurst SD, Caro I, Rooney I, Hegde PS, Molinero L, Yue H, Chang I, Amler L, Yan Y, Ribas A. Wongchenko MJ, et al. Clin Cancer Res. 2017 Sep 1;23(17):5238-5245. doi: 10.1158/1078-0432.CCR-17-0172. Epub 2017 May 23. Clin Cancer Res. 2017. PMID: 28536307

9

Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy.

van Dam PJ, Daelemans S, Ross E, Waumans Y, Van Laere S, Latacz E, Van Steen R, De Pooter C, Kockx M, Dirix L, Vermeulen PB. van Dam PJ, et al. Semin Cancer Biol. 2018 Oct;52(Pt 2):86-93. doi: 10.1016/j.semcancer.2018.01.009. Epub 2018 Jan 31. Semin Cancer Biol. 2018. PMID: 29355613 Review.

10

Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases.

Stremitzer S, Vermeulen P, Graver S, Kockx M, Dirix L, Yang D, Zhang W, Stift J, Wrba F, Gruenberger T, Lenz HJ, Scherer SJ. Stremitzer S, et al. Br J Cancer. 2020 May;122(10):1518-1524. doi: 10.1038/s41416-020-0812-z. Epub 2020 Mar 24. Br J Cancer. 2020. PMID: 32205863 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

170 results

Search Page